Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 36%
Hold 43%
Sell 7%
Strong Sell 0%

Bulls say

Henry Schein is a financially sound company with strong leadership and a successful cost-reduction strategy, positioning them as a leader in the dental industry. With their focus on transforming operations and expanding into the high-growth medical sector through strategic mergers and acquisitions, the company is well-positioned for long-term growth. Additionally, their commitment to improving overall oral health through partnerships with dental schools further reinforces their potential for success.

Bears say

Henry Schein is well-positioned to benefit from the stable growth of the dental industry and has a strong balance sheet and experienced leadership. However, potential risks such as competition and changes in healthcare legislation should be monitored. Furthermore, the company's recent strong performance and expected future growth, as well as the incoming CEO's experience in mergers and acquisitions, indicate potential for continued success. Additionally, while international markets may be mixed, HSIC is successfully gaining market share in key areas.

Henry Schein (HSIC) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 36% recommend Buy, 43% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Buy based on their latest research and market trends.

According to 14 analysts, Henry Schein (HSIC) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.